We stand by our peptide quality with an industry-leading 90-day return policy and a guarantee that our peptides meet or exceed 99% purity
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Les BPF sont les Bonnes Pratiques de Fabrication qui sont en vigueur dans l'industrie pharmaceutique de toute l'Europe
After analyzing the average number of IL-6, IL-1, TNF-, and COX-2 proteins expression using the Oneway Anova method, it showed differences in the amount of COX-2, TNF-, IL-1, and IL- 6 that were found
One way, two way or repeated ANOVA and appropriate post-hoc tests were used to identify significant differences, with a significance level set at p 0.9999)